Morgan Leigh Brown, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 21 | 2023 | 3537 | 2.160 |
Why?
|
| Heart Defects, Congenital | 11 | 2023 | 4584 | 1.450 |
Why?
|
| Aortic Coarctation | 3 | 2021 | 281 | 1.360 |
Why?
|
| Heart Ventricles | 8 | 2022 | 3821 | 1.250 |
Why?
|
| Anesthesia | 4 | 2022 | 1561 | 1.240 |
Why?
|
| Ebstein Anomaly | 4 | 2008 | 97 | 1.210 |
Why?
|
| Heart Valve Prosthesis | 7 | 2011 | 1488 | 1.150 |
Why?
|
| Fontan Procedure | 3 | 2022 | 778 | 1.110 |
Why?
|
| Aortic Valve | 7 | 2011 | 1922 | 0.950 |
Why?
|
| Anesthesia, General | 3 | 2022 | 1171 | 0.930 |
Why?
|
| Heart Valve Prosthesis Implantation | 11 | 2011 | 1536 | 0.920 |
Why?
|
| Postoperative Nausea and Vomiting | 2 | 2022 | 119 | 0.880 |
Why?
|
| Intraoperative Complications | 3 | 2018 | 1198 | 0.870 |
Why?
|
| Heart-Assist Devices | 3 | 2019 | 1194 | 0.820 |
Why?
|
| Bioprosthesis | 3 | 2011 | 596 | 0.750 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2010 | 1265 | 0.750 |
Why?
|
| Thoracic Surgery | 2 | 2023 | 719 | 0.700 |
Why?
|
| Hypertension, Pulmonary | 2 | 2022 | 1537 | 0.700 |
Why?
|
| Thyroid Diseases | 1 | 2021 | 379 | 0.610 |
Why?
|
| Tachycardia | 1 | 2020 | 619 | 0.600 |
Why?
|
| Norwood Procedures | 1 | 2019 | 182 | 0.590 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 1912 | 0.590 |
Why?
|
| Surgical Procedures, Operative | 3 | 2018 | 1876 | 0.560 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 426 | 0.550 |
Why?
|
| Williams Syndrome | 1 | 2018 | 187 | 0.540 |
Why?
|
| Catheter Ablation | 3 | 2020 | 2758 | 0.530 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2010 | 579 | 0.520 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 345 | 0.520 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 514 | 0.480 |
Why?
|
| Postoperative Complications | 11 | 2022 | 15295 | 0.480 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2019 | 574 | 0.460 |
Why?
|
| Airway Management | 1 | 2017 | 329 | 0.450 |
Why?
|
| Down Syndrome | 1 | 2021 | 880 | 0.450 |
Why?
|
| Pulmonary Valve | 1 | 2017 | 437 | 0.430 |
Why?
|
| Preoperative Care | 1 | 2021 | 2250 | 0.410 |
Why?
|
| Tetralogy of Fallot | 1 | 2017 | 623 | 0.400 |
Why?
|
| Mitral Valve | 3 | 2010 | 1491 | 0.390 |
Why?
|
| Heart Valve Diseases | 3 | 2008 | 1073 | 0.390 |
Why?
|
| Anesthesiology | 2 | 2022 | 1060 | 0.380 |
Why?
|
| Aortic Valve Stenosis | 4 | 2011 | 1965 | 0.370 |
Why?
|
| Operating Room Information Systems | 1 | 2009 | 15 | 0.360 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2132 | 0.360 |
Why?
|
| Heart Diseases | 2 | 2021 | 2788 | 0.350 |
Why?
|
| Mediastinitis | 1 | 2009 | 48 | 0.350 |
Why?
|
| Perioperative Care | 1 | 2017 | 1002 | 0.340 |
Why?
|
| Heart Valves | 1 | 2011 | 291 | 0.340 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2008 | 46 | 0.330 |
Why?
|
| Child | 19 | 2022 | 77709 | 0.320 |
Why?
|
| Data Mining | 2 | 2010 | 537 | 0.320 |
Why?
|
| Mammary Arteries | 1 | 2008 | 70 | 0.320 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2010 | 859 | 0.320 |
Why?
|
| Atrial Septum | 1 | 2008 | 60 | 0.310 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 1422 | 0.310 |
Why?
|
| Systole | 2 | 2009 | 958 | 0.310 |
Why?
|
| Child, Preschool | 14 | 2022 | 41006 | 0.310 |
Why?
|
| Infant | 13 | 2022 | 35136 | 0.310 |
Why?
|
| Retrospective Studies | 22 | 2022 | 77449 | 0.310 |
Why?
|
| Sternum | 1 | 2008 | 177 | 0.300 |
Why?
|
| Coronary Artery Bypass | 4 | 2011 | 2289 | 0.300 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 194 | 0.300 |
Why?
|
| Survival Rate | 10 | 2021 | 12788 | 0.300 |
Why?
|
| Medical Records | 2 | 2013 | 1413 | 0.300 |
Why?
|
| Heart Septum | 1 | 2008 | 313 | 0.290 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 549 | 0.290 |
Why?
|
| Mediastinum | 1 | 2008 | 267 | 0.290 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2011 | 501 | 0.290 |
Why?
|
| Electronic Health Records | 2 | 2016 | 4468 | 0.290 |
Why?
|
| Treatment Outcome | 22 | 2022 | 63114 | 0.280 |
Why?
|
| Humans | 61 | 2023 | 744343 | 0.280 |
Why?
|
| Pediatrics | 2 | 2022 | 3475 | 0.270 |
Why?
|
| Thrombosis | 3 | 2019 | 2968 | 0.270 |
Why?
|
| Pain, Postoperative | 5 | 2022 | 1643 | 0.270 |
Why?
|
| Societies, Medical | 3 | 2023 | 3743 | 0.260 |
Why?
|
| Tricuspid Valve | 1 | 2008 | 403 | 0.260 |
Why?
|
| Aorta | 1 | 2013 | 2061 | 0.260 |
Why?
|
| Mediastinal Neoplasms | 1 | 2008 | 423 | 0.260 |
Why?
|
| Iatrogenic Disease | 1 | 2008 | 547 | 0.250 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 793 | 0.250 |
Why?
|
| Male | 38 | 2022 | 350118 | 0.240 |
Why?
|
| Aorta, Thoracic | 1 | 2010 | 1082 | 0.240 |
Why?
|
| Female | 37 | 2022 | 380194 | 0.230 |
Why?
|
| Time Factors | 12 | 2020 | 40075 | 0.210 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2002 | 195 | 0.200 |
Why?
|
| Schizosaccharomyces pombe Proteins | 1 | 2002 | 178 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2007 | 506 | 0.200 |
Why?
|
| Adult | 24 | 2022 | 214055 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2009 | 2073 | 0.190 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 237 | 0.190 |
Why?
|
| Reoperation | 4 | 2013 | 4201 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 1 | 2009 | 1475 | 0.180 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 2212 | 0.180 |
Why?
|
| Incidence | 6 | 2020 | 20947 | 0.180 |
Why?
|
| Databases as Topic | 3 | 2010 | 475 | 0.180 |
Why?
|
| Professional Practice | 1 | 2022 | 326 | 0.180 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39050 | 0.170 |
Why?
|
| Patient Care Team | 1 | 2011 | 2531 | 0.170 |
Why?
|
| Coronary Angiography | 2 | 2008 | 4577 | 0.160 |
Why?
|
| Fungal Proteins | 1 | 2002 | 912 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.160 |
Why?
|
| Middle Aged | 21 | 2015 | 213383 | 0.160 |
Why?
|
| Aged | 19 | 2015 | 163280 | 0.160 |
Why?
|
| Vascular Patency | 3 | 2010 | 886 | 0.160 |
Why?
|
| Pulmonary Circulation | 2 | 2019 | 739 | 0.160 |
Why?
|
| Catheters | 1 | 2021 | 425 | 0.150 |
Why?
|
| Intraoperative Period | 2 | 2009 | 520 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 3610 | 0.150 |
Why?
|
| Risk Assessment | 9 | 2015 | 23338 | 0.150 |
Why?
|
| Registries | 3 | 2010 | 8089 | 0.150 |
Why?
|
| Echocardiography, Transesophageal | 3 | 2008 | 1133 | 0.150 |
Why?
|
| Electrophysiology | 1 | 2020 | 1308 | 0.140 |
Why?
|
| Factor VIIa | 1 | 2017 | 101 | 0.140 |
Why?
|
| Adolescent | 10 | 2021 | 85781 | 0.140 |
Why?
|
| Morphine | 1 | 2021 | 657 | 0.140 |
Why?
|
| Palliative Care | 4 | 2019 | 3493 | 0.140 |
Why?
|
| Survival Analysis | 5 | 2009 | 10252 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 3396 | 0.140 |
Why?
|
| Length of Stay | 5 | 2022 | 6309 | 0.140 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3589 | 0.140 |
Why?
|
| Vascular Resistance | 1 | 2019 | 936 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1105 | 0.140 |
Why?
|
| Severity of Illness Index | 8 | 2010 | 15540 | 0.130 |
Why?
|
| DNA Replication | 1 | 2002 | 1399 | 0.130 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 1912 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 642 | 0.120 |
Why?
|
| Nerve Block | 1 | 2020 | 644 | 0.120 |
Why?
|
| DNA Repair | 1 | 2002 | 2046 | 0.110 |
Why?
|
| Infant, Newborn | 4 | 2019 | 25625 | 0.110 |
Why?
|
| Probability | 2 | 2008 | 2505 | 0.110 |
Why?
|
| Stroke Volume | 4 | 2010 | 5007 | 0.110 |
Why?
|
| Research Design | 1 | 2008 | 5987 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2022 | 4199 | 0.110 |
Why?
|
| Blood Transfusion | 1 | 2019 | 1301 | 0.100 |
Why?
|
| Ultrasonography | 3 | 2010 | 5985 | 0.100 |
Why?
|
| Echocardiography | 3 | 2010 | 5102 | 0.100 |
Why?
|
| Aged, 80 and over | 8 | 2015 | 57776 | 0.100 |
Why?
|
| Young Adult | 5 | 2022 | 56430 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 9959 | 0.100 |
Why?
|
| Minnesota | 2 | 2010 | 344 | 0.100 |
Why?
|
| Axillary Vein | 1 | 2010 | 16 | 0.100 |
Why?
|
| Quality Control | 2 | 2010 | 841 | 0.090 |
Why?
|
| Axillary Artery | 1 | 2010 | 50 | 0.090 |
Why?
|
| Operating Rooms | 2 | 2022 | 817 | 0.090 |
Why?
|
| Cyanosis | 1 | 2010 | 83 | 0.090 |
Why?
|
| Poisson Distribution | 1 | 2011 | 513 | 0.090 |
Why?
|
| Swine | 2 | 2011 | 5917 | 0.090 |
Why?
|
| Forms and Records Control | 1 | 2009 | 160 | 0.080 |
Why?
|
| Prognosis | 5 | 2021 | 29063 | 0.080 |
Why?
|
| Sternotomy | 1 | 2009 | 121 | 0.080 |
Why?
|
| Cohort Studies | 5 | 2013 | 40561 | 0.080 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 3674 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2023 | 7729 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2018 | 1470 | 0.080 |
Why?
|
| Echocardiography, Doppler | 2 | 2010 | 935 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2009 | 623 | 0.080 |
Why?
|
| Comorbidity | 2 | 2015 | 10388 | 0.080 |
Why?
|
| Balloon Occlusion | 1 | 2008 | 126 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2022 | 9146 | 0.080 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2010 | 277 | 0.070 |
Why?
|
| Risk Factors | 7 | 2016 | 72290 | 0.070 |
Why?
|
| Hypertension | 3 | 2013 | 8480 | 0.070 |
Why?
|
| Observation | 1 | 2008 | 312 | 0.070 |
Why?
|
| Thoracic Neoplasms | 1 | 2008 | 268 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2007 | 143 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 269 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2569 | 0.070 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 987 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25043 | 0.070 |
Why?
|
| Peer Review, Research | 1 | 2008 | 329 | 0.060 |
Why?
|
| Catheterization | 1 | 2010 | 1470 | 0.060 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2008 | 342 | 0.060 |
Why?
|
| Proportional Hazards Models | 2 | 2010 | 12354 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2008 | 12245 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2010 | 15076 | 0.060 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2006 | 272 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15165 | 0.060 |
Why?
|
| Observer Variation | 1 | 2010 | 2593 | 0.060 |
Why?
|
| Waiting Lists | 1 | 2008 | 692 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2008 | 770 | 0.060 |
Why?
|
| United States | 6 | 2022 | 69872 | 0.060 |
Why?
|
| Canada | 1 | 2008 | 2065 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2010 | 19905 | 0.060 |
Why?
|
| Hospitalization | 1 | 2022 | 10262 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2008 | 2971 | 0.050 |
Why?
|
| Fibrosis | 1 | 2009 | 2029 | 0.050 |
Why?
|
| Prosthesis Failure | 1 | 2007 | 1206 | 0.050 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 1205 | 0.050 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 44 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 818 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.050 |
Why?
|
| Creatinine | 1 | 2007 | 1919 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2016 | 5317 | 0.050 |
Why?
|
| Ligases | 1 | 2002 | 333 | 0.050 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1462 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2009 | 2488 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2008 | 1873 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2010 | 1390 | 0.050 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2002 | 502 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6895 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 1074 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6538 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6365 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2022 | 269 | 0.040 |
Why?
|
| Patient Selection | 2 | 2008 | 4215 | 0.040 |
Why?
|
| Patient Participation | 1 | 2008 | 1457 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 2050 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2020 | 53288 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2002 | 1266 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 2839 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 2892 | 0.040 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2017 | 76 | 0.040 |
Why?
|
| Critical Care | 2 | 2022 | 2647 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4320 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2009 | 8324 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3670 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2007 | 2708 | 0.030 |
Why?
|
| Career Choice | 1 | 2022 | 744 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13408 | 0.030 |
Why?
|
| Health Status | 1 | 2008 | 4034 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2008 | 3110 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2008 | 6077 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14722 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 1861 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 1888 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2002 | 2924 | 0.030 |
Why?
|
| DNA Damage | 1 | 2002 | 2432 | 0.030 |
Why?
|
| Cell Survival | 1 | 2002 | 5882 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 7279 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6487 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13815 | 0.020 |
Why?
|
| Heart Bypass, Right | 1 | 2010 | 74 | 0.020 |
Why?
|
| Propensity Score | 1 | 2017 | 1781 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2008 | 5034 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 18111 | 0.020 |
Why?
|
| Polycythemia | 1 | 2010 | 126 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 168757 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6622 | 0.020 |
Why?
|
| Quality of Life | 1 | 2008 | 12804 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2010 | 1423 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 4986 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2010 | 1534 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2022 | 5788 | 0.010 |
Why?
|
| Age Factors | 2 | 2008 | 18370 | 0.010 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 1831 | 0.010 |
Why?
|
| Cause of Death | 1 | 2010 | 3584 | 0.010 |
Why?
|
| Oxygen | 1 | 2010 | 4189 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 29786 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 10397 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2007 | 3445 | 0.010 |
Why?
|